Excelsior Medical Co., Ltd. (TPE:4104)
Taiwan
· Delayed Price · Currency is TWD 71.90
-0.60 (-0.83%)
Apr 29, 2026, 1:30 PM CST
Excelsior Medical Revenue
In the year 2025, Excelsior Medical had annual revenue of 8.79B TWD with 2.94% growth. Excelsior Medical had revenue of 2.28B in the quarter ending December 31, 2025, with 0.12% growth.
Revenue
8.79B
Revenue Growth
+2.94%
P/S Ratio
1.40
Revenue / Employee
63.69M
Employees
138
Market Cap
12.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.79B | 250.69M | 2.94% |
| Dec 31, 2024 | 8.54B | 305.14M | 3.71% |
| Dec 31, 2023 | 8.23B | 1.05B | 14.56% |
| Dec 31, 2022 | 7.19B | 613.68M | 9.34% |
| Dec 31, 2021 | 6.57B | -102.34M | -1.53% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 15.63B |
| Caliway Biopharmaceuticals | 38.04M |
| Heron Neutron Medical | 12.96M |
| Lotus Pharmaceutical | 20.51B |
| TaiMed Biologics | 611.35M |
| Handa Pharmaceuticals | 1.73B |
| Foresee Pharmaceuticals | 431.27M |
| Locus Cell | 12.74M |